Investing in Arcutis Biotherapeutics Inc (ARQT): What You Must Know

In a filing, Arcutis Biotherapeutics Inc revealed its Director Welgus Howard G. acquired Company’s shares for reported $0.13 million on Jul 01 ’25. In the deal valued at $13.84 per share,9,208 shares were bought.

Then, Welgus Howard G. sold 10,139 shares, generating $135,574 in total proceeds. Upon selling the shares at $13.37, the Director now owns 109,414 shares.

Before that, Welgus Howard G. bought 10,139 shares. Arcutis Biotherapeutics Inc shares valued at $135,573 were divested by the Director at a price of $13.37 per share.

H.C. Wainwright initiated its Arcutis Biotherapeutics Inc [ARQT] rating to a Buy in a research note published on December 30, 2024; the price target was $19. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. Mizuho also remained covering ARQT and has increased its forecast on January 03, 2024 with a “Buy” recommendation from previously “Neutral” rating. Mizuho revised its rating on October 26, 2023. It rated ARQT as “a Neutral” which previously was an “a Buy”.

Price Performance Review of ARQT

On Tuesday, Arcutis Biotherapeutics Inc [NASDAQ:ARQT] saw its stock fall -1.93% to $13.75. Over the last five days, the stock has lost -4.05%. Arcutis Biotherapeutics Inc shares have risen nearly 45.97% since the year began. Nevertheless, the stocks have fallen -1.29% over the past one year. While a 52-week high of $17.75 was reached on 03/25/25, a 52-week low of $7.86 was recorded on 02/11/25.

Levels Of Support And Resistance For ARQT Stock

The 24-hour chart illustrates a support level at 13.50, which if violated will result in even more drops to 13.24. On the upside, there is a resistance level at 14.16. A further resistance level may holdings at 14.56.

How much short interest is there in Arcutis Biotherapeutics Inc?

A steep rise in short interest was recorded in Arcutis Biotherapeutics Inc stocks on 2025-06-13, growing by 2.61 million shares to a total of 18.64 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 16.04 million shares. There was a rise of 13.99%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.